RIAD, Arabia Saudí, 2 de diciembre de 2025 /PRNewswire/ — Bajo el patrocinio del Custodio de las Dos Mezquitas Sagradas, el Rey Salman bin Abdulaziz Al Saud, el Ministerio de Recursos Humanos y Desarrollo Social ha anunciado que organizará la tercera edición de la Conferencia Mundial del Mercado Laboral (GLMC) en el Centro Internacional de… Continue reading Riad acogerá la tercera edición de la Conferencia Mundial del Mercado Laboral en enero
Author: PR Newswire Online News
Revizto unveils new solution to reduce cost overruns and speed up delivery on major infrastructure programs
Eliminating the industry’s top workflow bottleneck: the manual setup that slows navigation across linear projects LAUSANNE, Switzerland, Dec. 2, 2025 /PRNewswire/ — Revizto, a leading integrated collaboration platform used across the architecture, engineering, and construction (AECO) industry, today announces the launch of Revizto for Infrastructure, a new solution for complex long-distance linear projects, including highways,… Continue reading Revizto unveils new solution to reduce cost overruns and speed up delivery on major infrastructure programs
Riad ist Gastgeber der dritten Ausgabe der globalen Arbeitsmarktkonferenz im Januar
RIYADH, Saudi-Arabien, 2. Dezember 2025 /PRNewswire/ — Unter der Schirmherrschaft des Kustos der beiden Heiligen Moscheen, König Salman bin Abdulaziz Al Saud, hat das Ministerium für Humanressourcen und soziale Entwicklung bekannt gegeben, dass es am 26. und 27. Januar 2026 die dritte Ausgabe der Globalen Arbeitsmarktkonferenz (GLMC) im King Abdulaziz International Conference Center (KAICC) in Riad… Continue reading Riad ist Gastgeber der dritten Ausgabe der globalen Arbeitsmarktkonferenz im Januar
Riyad accueillera la troisième édition de la conférence mondiale sur le marché du travail en janvier
RIYADH, Arabie Saoudite, 2 décembre 2025 /PRNewswire/ — Sous le patronage du Gardien des Deux Saintes Mosquées, le Roi Salman bin Abdulaziz Al Saud, le Ministère des Ressources Humaines et du Développement Social a annoncé qu’il accueillera la troisième édition de la Conférence Mondiale sur le Marché du Travail (GLMC) au King Abdulaziz International Conference Center… Continue reading Riyad accueillera la troisième édition de la conférence mondiale sur le marché du travail en janvier
POWERCHINA’s Global Team Advances Inclusive Growth with Localized Approach through Empowerment, Respect, and Cultural Collaboration
BEIJING, Dec. 2, 2025 /PRNewswire/ — Power Construction Corporation of China (“POWERCHINA” or “the Company”), with multiple infrastructure projects across six continents, focuses on connections that foster cultural exchange and shared development. Through local employment, cross-cultural integration, community festivals, environmental protection, and employee empowerment, the Company promotes inclusive growth and demonstrates its commitment to people, society, and… Continue reading POWERCHINA’s Global Team Advances Inclusive Growth with Localized Approach through Empowerment, Respect, and Cultural Collaboration
DocuPet Welcomes Abbie Moore as Chief Product Officer
Driving innovation in pet safety, digital experiences and the next-gen pet parenting mobile app SYRACUSE, N.Y., Dec. 2, 2025 /PRNewswire/ — DocuPet, a leading pet registration, identification and lost pet reunification platform, is pleased to announce that Abbie Moore has joined the company as Chief Product Officer (CPO). Moore will oversee all aspects of product strategy,… Continue reading DocuPet Welcomes Abbie Moore as Chief Product Officer
New historical thriller ‘Where The Truth Was Buried’ tells a story of espionage, sacrifice and a son’s search for the truth
Dan Mulvagh blends history with suspense as a man uncovers the wartime secrets that shaped his identity AUCKLAND, New Zealand, Dec. 2, 2025 /PRNewswire/ — Dan Mulvagh delivers a powerful and emotionally charged narrative in “Where The Truth Was Buried: A story of espionage, betrayal, and the long shadow of WW2” (published by Xlibris NZ). Having been… Continue reading New historical thriller ‘Where The Truth Was Buried’ tells a story of espionage, sacrifice and a son’s search for the truth
GC Biopharma’s Varicella Vaccine Strain ‘MAV/06’ Listed in WHO Position Paper
Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply security YONGIN, South Korea, Dec. 2, 2025 /PRNewswire/ — GC Biopharma (006280.KS), a global biopharmaceutical company, today announced that its proprietary varicella vaccine strain MAV/06 has been included in the World Health Organization (WHO) Position Paper on varicella vaccination, published on… Continue reading GC Biopharma’s Varicella Vaccine Strain ‘MAV/06’ Listed in WHO Position Paper
New historical thriller ‘Where The Truth Was Buried’ tells a story of espionage, sacrifice and a son’s search for the truth
Dan Mulvagh blends history with suspense as a man uncovers the wartime secrets that shaped his identity AUCKLAND, New Zealand, Dec. 2, 2025 /PRNewswire/ — Dan Mulvagh delivers a powerful and emotionally charged narrative in “Where The Truth Was Buried: A story of espionage, betrayal, and the long shadow of WW2” (published by Xlibris NZ). Having been… Continue reading New historical thriller ‘Where The Truth Was Buried’ tells a story of espionage, sacrifice and a son’s search for the truth
AbbVie präsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die Überlegenheit von Atogepant (AQUIPTA®) gegenüber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migräne belegen
Die entscheidende Phase-3-Studie ECLIPSE hat gezeigt, dass Atogepant Placebo hinsichtlich der Schmerzfreiheit zwei Stunden nach der Behandlung des ersten Migräneanfalls überlegen ist (24,3 % für Atogepant gegenüber 13,1 % für Placebo)1 AbbVie hat bei der Europäischen Arzneimittelagentur einen Antrag auf erweiterte Zulassung von Atogepant zur akuten Behandlung von Erwachsenen mit Migräne in ganz Europa eingereicht… Continue reading AbbVie präsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die Überlegenheit von Atogepant (AQUIPTA®) gegenüber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migräne belegen